• L04AG03 3 medications
• L04AG04 3 medications
• L04AG05 2 medications
• L04AG06 1 medications
• L04AG08 1 medications
• L04AG10 1 medications
• L04AG11 1 medications
• L04AG12 1 medications
• L04AG14 1 medications

medicationsWithCode L04AG

• Benlysta 120 mg powder for concentrate for infusion solution

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  BELIMUMAB	120 mg

  ATC code: L04A, L04AG, L04AG04

  Manufacturer: Glaxosmithkline (Ireland) Limited

• Benlysta 200 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  BELIMUMAB	200 mg

  ATC code: L04A, L04AG, L04AG04

  Manufacturer: Glaxosmithkline (Ireland) Limited

• Benlysta 400 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  BELIMUMAB	400 mg

  ATC code: L04A, L04AG, L04AG04

  Manufacturer: Glaxosmithkline (Ireland) Limited

• Briumvi 150 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  UBLITUXIMAB	150 mg

  ATC code: L04A, L04AG, L04AG14

  Manufacturer: Neuraxpharm Pharmaceuticals S.L.

• Entyvio 108 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  VEDOLIZUMAB	108 mg

  ATC code: L04A, L04AG, L04AG05

  Manufacturer: Takeda Pharma A/S

• Entyvio 300 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  VEDOLIZUMAB	300 mg

  ATC code: L04A, L04AG, L04AG05

  Manufacturer: Takeda Pharma A/S

• Kesimpta 20 mg solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  OFATUMUMAB	20 mg

  ATC code: L04A, L04AG, L04AG12

  Manufacturer: Novartis Europharm Limited

• Lemtrada 12 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  ALEMTUZUMAB	10,0 mg

  ATC code: L04A, L04AG, L04AG06

  Manufacturer: Sanofi Belgium

• Ocrevus 300 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  OCRELIZUMAB	30 mg

  ATC code: L04A, L04AG, L04AG08

  Manufacturer: Roche Registration Gmbh

• Saphnelo 300 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  ANIFROLUMAB	300 mg

  ATC code: L04A, L04AG, L04AG11

  Manufacturer: Astrazeneca Ab

• Tyruko 300 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  NATALIZUMAB	300 mg

  ATC code: L04A, L04AG, L04AG03

  Manufacturer: Sandoz Gmbh

• Tysabri 150 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  NATALIZUMAB	150 mg/ml

  ATC code: L04A, L04AG, L04AG03

  Manufacturer: Biogen Netherlands B.V.

• Tysabri 300 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  NATALIZUMAB	20 mg

  ATC code: L04A, L04AG, L04AG03

  Manufacturer: Biogen Netherlands B.V.

• Uplizna 100 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  INEBILIZUMAB	10 mg/ml

  ATC code: L04A, L04AG, L04AG10

  Manufacturer: Amgen Europe B.V.